| __timestamp | Travere Therapeutics, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 27632226 | 21584000 |
| Thursday, January 1, 2015 | 97707000 | 28006000 |
| Friday, January 1, 2016 | 129037000 | 39623000 |
| Sunday, January 1, 2017 | 151332000 | 43758000 |
| Monday, January 1, 2018 | 158719000 | 58930000 |
| Tuesday, January 1, 2019 | 170104000 | 83845000 |
| Wednesday, January 1, 2020 | 192195000 | 76028000 |
| Friday, January 1, 2021 | 220706000 | 145114000 |
| Saturday, January 1, 2022 | 204426000 | 194954000 |
| Sunday, January 1, 2023 | 133788000 | 248148000 |
In pursuit of knowledge
In the dynamic world of biotechnology, financial performance is a key indicator of a company's growth and stability. This analysis delves into the gross profit trends of Veracyte, Inc. and Travere Therapeutics, Inc. over the past decade, from 2014 to 2023.
Veracyte, Inc. has shown a remarkable upward trajectory, with its gross profit increasing by over 1,000% from 2014 to 2023. Notably, the company experienced a significant surge in 2023, reaching its highest gross profit of approximately $248 million. In contrast, Travere Therapeutics, Inc. demonstrated a more fluctuating pattern, peaking in 2021 with a gross profit of around $221 million, before experiencing a decline in 2023.
These trends highlight the competitive landscape of the biotech industry, where strategic innovation and market adaptation are crucial for sustained financial success.
Gross Profit Analysis: Comparing AstraZeneca PLC and Veracyte, Inc.
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Veracyte, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Gross Profit Trends Compared: Ascendis Pharma A/S vs Veracyte, Inc.
Gross Profit Comparison: Jazz Pharmaceuticals plc and Veracyte, Inc. Trends
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Veracyte, Inc. and Travere Therapeutics, Inc.
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown